Table 2 Comparison of outcomes and administered regimens for long-term survivors and non-long-term survivor

ORR (%)*

44.9

82.6

17.9

<0.00001

CBR (%)*

63.3

100

35.7

<0.00001

TTF*

10

26

5

0

TTP*

18

34

5

0

OS*

38

68

17

<0.00001

OS from diagnosis of MBC

52

113

20

<0.00001

Number Of chemotherapy regimens*

1 (0-3)

1 (0-3)

1 (0-3)

0.66

Number of chemotherapy regimens for BC

3 (1-7)

4 (1-7)

4 (1-6)

0.36

Number of chemotherapy regimens for MBC

3 (1-7)

3 (1-7)

3 (1-5)

0.2